SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Exelixis, Inc. (EXEL)
EXEL 42.54+1.8%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (189)11/7/2005 6:38:21 AM
From: rkrw  Read Replies (1) of 930
 
Groupie, Finally got the cc. I had no idea exel had a gleevec t351 resistance candidate. Whomever wins that race will have a very big and important drug. May as well be exel :-)

Things will starting looking much more clear and fun once gsk makes their selections and exel has the other 10 or so unencumbered.

Put mygn with exel and you'll have about a 20 product pipeline in a couple of years.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext